
Q2 EPS Estimates for SelectQuote Lowered by Noble Financial

Noble Financial has lowered its Q2 2026 earnings per share (EPS) estimate for SelectQuote, Inc. (NYSE:SLQT) from $0.19 to $0.17. The consensus estimate for the company's full-year earnings is ($0.07) per share. Other analysts have varied opinions, with Zacks upgrading the stock to a "hold" rating, while Weiss Ratings maintained a "sell" rating. SelectQuote's stock opened at $1.74, with a market cap of $305.15 million and a consensus rating of "hold" with an average price target of $4.38.
- Is SelectQuote a Double-Bagger Stock? Analysts Predict Huge Gains
SelectQuote, Inc. (NYSE:SLQT - Free Report) - Noble Financial decreased their Q2 2026 earnings per share (EPS) estimates for shares of SelectQuote in a report released on Friday, November 7th. Noble Financial analyst P. Mccann now anticipates that the company will post earnings of $0.17 per share for the quarter, down from their prior forecast of $0.19. The consensus estimate for SelectQuote's current full-year earnings is ($0.07) per share.
A number of other research firms have also recently commented on SLQT. Zacks Research raised shares of SelectQuote from a "strong sell" rating to a "hold" rating in a research note on Wednesday, October 22nd. Weiss Ratings reiterated a "sell (d)" rating on shares of SelectQuote in a report on Wednesday, October 8th. Finally, Royal Bank Of Canada lowered their price objective on SelectQuote from $7.00 to $6.00 and set a "sector perform" rating for the company in a research report on Tuesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, SelectQuote presently has a consensus rating of "Hold" and an average price target of $4.38.
- 3 Small-Cap Stocks to Buy and Hold For 2025 and Beyond
Read Our Latest Stock Analysis on SLQT
SelectQuote Stock Performance
NYSE SLQT opened at $1.74 on Monday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 5.42 and a current ratio of 5.42. SelectQuote has a fifty-two week low of $1.62 and a fifty-two week high of $6.86. The stock has a 50-day simple moving average of $2.02 and a two-hundred day simple moving average of $2.19. The firm has a market capitalization of $305.15 million, a P/E ratio of 34.70 and a beta of 1.26.
SelectQuote (NYSE:SLQT - Get Free Report) last issued its quarterly earnings data on Thursday, November 6th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $0.01. SelectQuote had a net margin of 3.95% and a return on equity of 10.41%. The firm had revenue of $328.81 million for the quarter, compared to the consensus estimate of $323.68 million. SelectQuote has set its FY 2026 guidance at EPS.
Institutional Trading of SelectQuote
Institutional investors have recently bought and sold shares of the business. Virtu Financial LLC acquired a new stake in shares of SelectQuote in the first quarter valued at approximately $34,000. Xponance Inc. purchased a new stake in SelectQuote in the 1st quarter valued at $34,000. Kapitalo Investimentos Ltda acquired a new stake in SelectQuote during the 1st quarter worth $35,000. Nations Financial Group Inc. IA ADV acquired a new stake in SelectQuote during the 1st quarter worth $40,000. Finally, Headlands Technologies LLC grew its position in SelectQuote by 86.7% during the 1st quarter. Headlands Technologies LLC now owns 12,398 shares of the company's stock worth $41,000 after purchasing an additional 5,756 shares during the last quarter. 34.59% of the stock is owned by hedge funds and other institutional investors.
SelectQuote Company Profile
(Get Free Report)SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Featured Articles
- Five stocks we like better than SelectQuote
- What is the Hang Seng index?
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- How to trade penny stocks: A step-by-step guide
- Is Robinhood's 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- AI Demand Is Coming—Is Microchip Technology Ready?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in SelectQuote Right Now?
Before you consider SelectQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.
While SelectQuote currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

